Antagonism of mGlu2/3 receptors in the nucleus accumbens prevents oxytocin from reducing cued methamphetamine seeking in male and female rats
A Bernheim, KC Leong, C Berini, CM Reichel - … Biochemistry and Behavior, 2017 - Elsevier
Methamphetamine (meth) addiction is a prevalent health concern worldwide, yet remains
without approved pharmacological treatments. Preclinical evidence suggests that oxytocin …
without approved pharmacological treatments. Preclinical evidence suggests that oxytocin …
[引用][C] Antagonism of mGlu2/3 receptors in the nucleus accumbens prevents oxytocin from reducing cued methamphetamine seeking in male and female rats
A Bernheim, KC Leong, C Berini… - … Biochemistry and Behavior, 2017 - cir.nii.ac.jp
Antagonism of mGlu2/3 receptors in the nucleus accumbens prevents oxytocin from reducing
cued methamphetamine seeking in male and female rats | CiNii Research CiNii 国立情報学 …
cued methamphetamine seeking in male and female rats | CiNii Research CiNii 国立情報学 …
Antagonism of mGlu2/3 receptors in the nucleus accumbens prevents oxytocin from reducing cued methamphetamine seeking in male and female rats
A Bernheim, KC Leong, C Berini… - Pharmacology …, 2017 - pubmed.ncbi.nlm.nih.gov
Methamphetamine (meth) addiction is a prevalent health concern worldwide, yet remains
without approved pharmacological treatments. Preclinical evidence suggests that oxytocin …
without approved pharmacological treatments. Preclinical evidence suggests that oxytocin …
[HTML][HTML] Antagonism of mGlu2/3 receptors in the nucleus accumbens prevents oxytocin from reducing cued methamphetamine seeking in male and female rats
A Bernheim, KC Leong, C Berini… - Pharmacology …, 2017 - ncbi.nlm.nih.gov
Methamphetamine (meth) addiction is a prevalent health concern worldwide, yet remains
without approved pharmacological treatments. Preclinical evidence suggests that oxytocin …
without approved pharmacological treatments. Preclinical evidence suggests that oxytocin …
Antagonism of mGlu2/3 receptors in the nucleus accumbens prevents oxytocin from reducing cued methamphetamine seeking in male and female rats.
A Bernheim, KC Leong, C Berini… - Pharmacology …, 2017 - psycnet.apa.org
Methamphetamine (meth) addiction is a prevalent health concern worldwide, yet remains
without approved pharmacological treatments. Preclinical evidence suggests that oxytocin …
without approved pharmacological treatments. Preclinical evidence suggests that oxytocin …
Antagonism of mGlu2/3 receptors in the nucleus accumbens prevents oxytocin from reducing cued methamphetamine seeking in male and female rats.
A Bernheim, KC Leong, C Berini… - Pharmacology …, 2017 - europepmc.org
Methamphetamine (meth) addiction is a prevalent health concern worldwide, yet remains
without approved pharmacological treatments. Preclinical evidence suggests that oxytocin …
without approved pharmacological treatments. Preclinical evidence suggests that oxytocin …